Supported Research
Extended Funding: Synthetic Lethal Approaches to Treatment of FA Gene Mutant Head and Neck Cancer
Amount Funded: $25,000
Typical treatments for cancer involve conditioning that damages DNA and can therefore be harmful for people with Fanconi anemia, who cannot repair DNA. Researchers are testing drugs using patient-derived xenografts (tumors from patients that are grown in mice) to find a way to kill FA cells without harming normal cells.
This grant is an extension of the 2020 grant of the same name.
Researchers: Barbara Burtness , Gary Kupfer